Murnane, Coley, and Baeten respond to "every good randomization deserves observation".
作者信息
Murnane Pamela M, Coley R Yates, Baeten Jared M
出版信息
Am J Epidemiol. 2015 Nov 15;182(10):861-2. doi: 10.1093/aje/kwv201. Epub 2015 Oct 19.
PMID:26487341
Abstract
摘要
相似文献
1
Murnane, Coley, and Baeten respond to "every good randomization deserves observation".莫尔纳内、科利和贝滕回应“每一次良好的随机分组都值得观察”。
Am J Epidemiol. 2015 Nov 15;182(10):861-2. doi: 10.1093/aje/kwv201. Epub 2015 Oct 19.
2
Invited commentary: every good randomization deserves observation.特邀评论：每一次良好的随机分组都值得观察。
Am J Epidemiol. 2015 Nov 15;182(10):857-60. doi: 10.1093/aje/kwv200. Epub 2015 Oct 19.
3
Pharmacologic-Based Methods of Adherence Assessment in HIV Prevention.基于药理学的HIV预防依从性评估方法
Clin Pharmacol Ther. 2018 Dec;104(6):1056-1059. doi: 10.1002/cpt.1201. Epub 2018 Sep 4.
4
[Not Available].[无可用内容]。
Rev Med Suisse. 2016 Aug 10;12(526):1346-1347.
5
[Protection against HIV - but only with good compliance!].预防艾滋病毒——但前提是要有良好的依从性！
MMW Fortschr Med. 2016 Jun 9;158 Suppl 1:11. doi: 10.1007/s15006-016-8316-8.
6
Estimating efficacy in a randomized trial with product nonadherence: application of multiple methods to a trial of preexposure prophylaxis for HIV prevention.在存在产品不依从性的随机试验中评估疗效：多种方法在HIV预防暴露前预防试验中的应用
Am J Epidemiol. 2015 Nov 15;182(10):848-56. doi: 10.1093/aje/kwv202. Epub 2015 Oct 19.
7
Progress and pitfalls in measuring HIV preexposure prophylaxis coverage in the United States.美国HIV暴露前预防覆盖率测量的进展与陷阱
Ann Epidemiol. 2018 Dec;28(12):830-832. doi: 10.1016/j.annepidem.2018.08.005. Epub 2018 Aug 24.
8
HOW DO I PAY FOR PrEP?我如何支付暴露前预防药物的费用？
Posit Aware. 2015 Summer;27(5):18-9.
9
MOVING FORWARD WITH PrEP. THE BASICS OF PrEP.推进暴露前预防。暴露前预防的基础知识。
Posit Aware. 2015 Summer;27(5):2-3.
10
Drug safety evaluation of oral tenofovir disoproxil fumarate-emtricitabine for pre-exposure prophylaxis for human immunodeficiency virus infection.口服替诺福韦酯-恩曲他滨用于人类免疫缺陷病毒感染暴露前预防的药物安全性评价。
Expert Opin Drug Saf. 2016 Sep;15(9):1287-94. doi: 10.1080/14740338.2016.1211108. Epub 2016 Jul 25.
Zotero 插件